EXOSOME-ENCAPSULATED microRNA-451a AS A CIRCULATING BIOMARKER FOR BREAST CANCER

被引:0
|
作者
Naughton, E. [1 ]
Bm, Moloney [2 ]
Gilligan, K. E. [2 ]
Joyce, D. P. [2 ]
Kerin, M. J. [2 ]
Dwyer, R. M. [2 ]
机构
[1] Univ Coll Dublin, UCD Sch Med, Dublin 4, Ireland
[2] Natl Univ Ireland Galway, Lambe Inst Translat Res, Sch Med, Discipline Surg, Galway, Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
8
引用
收藏
页码:S6 / S6
页数:1
相关论文
共 50 条
  • [21] Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
    Kim, Myung Soo
    Haney, Matthew J.
    Zhao, Yuling
    Mahajan, Vivek
    Deygen, Irina
    Klyachko, Natalia L.
    Inskoe, Eli
    Piroyan, Aleksandr
    Sokolsky, Marina
    Okolie, Onyi
    Hingtgen, Shawn D.
    Kabanov, Alexander V.
    Batrakova, Elena V.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (03) : 655 - 664
  • [22] Exosome-encapsulated microRNA-23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage
    Kumata, Yoshimasa
    Iinuma, Hisae
    Suzuki, Yusuke
    Tsukahara, Daisuke
    Midorikawa, Hironori
    Igarashi, Yuichi
    Soeda, Naruyoshi
    Kiyokawa, Takashi
    Horikawa, Masahiro
    Fukushima, Ryoji
    ONCOLOGY REPORTS, 2018, 40 (01) : 319 - 330
  • [23] MicroRNA-451a targets caveolin-1 in stomach cancer cells
    Wang, Yi
    Lin, Zhenmeng
    Song, Jintian
    Wei, Shengpong
    Ye, Zaisheng
    Chen, Shu
    Zeng, Yi
    Lin, Zhitao
    Chen, Xiaoling
    Chen, Luchuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (10): : 2524 - 2533
  • [24] Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer
    Soeda, Naruyoshi
    Iinuma, Hisae
    Suzuki, Yusuke
    Tsukahara, Daisuke
    Midorikawa, Hironori
    Igarashi, Yuichi
    Kumata, Yoshimasa
    Horikawa, Masahiro
    Kiyokawa, Takashi
    Fukagawa, Takeo
    Fukushima, Ryoji
    ONCOLOGY LETTERS, 2019, 18 (05) : 4467 - 4480
  • [25] Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer
    Gu, Xi
    Xue, Jin-Qi
    Han, Si-Jia
    Qian, Song-Ying
    Zhang, Wen-Hai
    CANCER BIOMARKERS, 2016, 16 (03) : 395 - 403
  • [26] MicroRNA-451a promotes cell proliferation, migration and invasion in cervical cancer cell lines
    Li, Lin
    Zhang, Jing
    Yuan, Lin
    Sun, Lei
    Cai, Yan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 2458 - 2464
  • [27] Targeted reversal of multidrug resistance in ovarian cancer cells using exosome-encapsulated tetramethylpyrazine
    Zhao, Chenge
    Qiu, Lulu
    Wu, Di
    Zhang, Ming
    Xia, Wanying
    Lv, Huiyi
    Cheng, Lichun
    MOLECULAR MEDICINE REPORTS, 2024, 29 (02)
  • [28] Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer
    Kanaoka, Rie
    Iinuma, Hisae
    Dejima, Hitoshi
    Sakai, Takashi
    Uehara, Hirofumi
    Matsutani, Noriyuki
    Kawamura, Masafumi
    ONCOLOGY, 2018, 94 (05) : 311 - 323
  • [29] Exosome: emerging biomarker in breast cancer
    Jia, Yunlu
    Chen, Yongxia
    Wang, Qinchuan
    Jayasinghe, Ushani
    Luo, Xiao
    Wei, Qun
    Wang, Ji
    Xiong, Hanchu
    Chen, Cong
    Xu, Bin
    Hu, Wenxian
    Wang, Linbo
    Zhao, Wenhe
    Zhou, Jichun
    ONCOTARGET, 2017, 8 (25) : 41717 - 41733
  • [30] Engineering Mesenchymal Stem Cells (MSCs) to support tumor-targeted delivery of exosome-encapsulated microRNA-379
    O'Brien, Killian P.
    Gilligan, Katie
    Khan, Sonja
    Moloney, Brian
    Thompson, Kerry
    Lalor, Pierce
    Dockery, Peter
    Ingoldsby, Helen
    Kerin, Michael J.
    Dwyer, Roisin M.
    CANCER RESEARCH, 2017, 77